5AM Ventures (“5AM”) is a leading investment firm focused on building next-generation life science companies capable of delivering outstanding returns to our investors. We support companies that are working to solve important healthcare needs via cutting-edge breakthroughs in medicine and science.
5AM was founded in 2002, has approximately $2.2 billion in capital commitments, and has invested in +170 companies to date. In addition to the venture funds, 5AM recently launched a new strategy investing in life science public companies and later stage private companies. The firm’s unique investment style and fully integrated platform employs fundamental primary research using a disciplined, process-oriented approach to both diligence and portfolio management.